Back to calendar
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
BCRX reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026
Q2 2026
Est. EPS: $0.09
Actual EPS: $0.30
EPS surprise: 94.58%
Company overview
Market Cap$2.4B
PriceUSD 9.38
EPS (TTM)-1.50
52-week high11.22
52-week low6.00
SectorHealth Technology
IndustryBiotechnology
Employees435